The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBeximco Pharma Regulatory News (BXP)

Share Price Information for Beximco Pharma (BXP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 36.50
Bid: 35.00
Ask: 38.00
Change: 0.00 (0.00%)
Spread: 3.00 (8.571%)
Open: 36.50
High: 36.50
Low: 36.50
Prev. Close: 36.50
BXP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Price Monitoring Extension

28 Aug 2020 11:00

RNS Number : 4757X
Beximco Pharmaceuticals Ltd
28 August 2020
 

Price Monitoring Extension

The auction call period has been extended in this security by 5 minutes.

Auction call extensions give London Stock Exchange electronic order book users a further opportunity to review the prices and sizes of orders entered in an individual security's auction call before the execution occurs. A price monitoring extension is activated when the matching process would have otherwise resulted in an execution price that is a pre-determined percentage above or below the price of the most recent automated execution today.

The applicable percentage is set by reference to a security's Millennium Exchange sector. This is set out in the Sector Breakdown tab of the Parameters document at www.londonstockexchange.com/tradingservices

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
PMEFLFIITIITFII
Date   Source Headline
24th Mar 20212:06 pmRNSSecond Price Monitoring Extn
24th Mar 20212:00 pmRNSPrice Monitoring Extension
24th Mar 202111:06 amRNSSecond Price Monitoring Extn
24th Mar 202111:00 amRNSPrice Monitoring Extension
4th Feb 20217:34 amRNSUpdate on the supply of COVID-19 vaccine
28th Jan 20217:00 amRNSHalf Year Results 2020-21
22nd Jan 20217:00 amRNSPayment of Cash Dividend
21st Jan 20219:34 amRNSProposed acquisition of stake in Sanofi Bangladesh
18th Jan 20217:00 amRNSBoard Changes
14th Jan 20219:00 amRNSUpdate on the supply of COVID-19 vaccine
11th Jan 20217:00 amRNSStock Dividend Issued
11th Jan 20217:00 amRNSConfirmation of Board Changes
21st Dec 20207:00 amRNSAGM Statement
2nd Dec 202011:01 amRNSBoard Changes
23rd Nov 20207:00 amRNSNotice of AGM
16th Nov 20207:00 amRNSResults for First Quarter Ended 30 September 2020
13th Nov 20207:00 amRNSResults for First Quarter Ended 30 September 2020
11th Nov 20207:00 amRNSResults for the year ended 30 June 2020
5th Nov 20204:40 pmRNSSecond Price Monitoring Extn
5th Nov 20204:35 pmRNSPrice Monitoring Extension
5th Nov 20202:40 pmRNSMOU with SII and GOB for COVID-19 vaccine
29th Oct 20207:00 amRNSNotification of Preliminary Results and AGM
21st Sep 20207:00 amRNSBeximco Pharma receives eighth FDA approval
28th Aug 202011:06 amRNSSecond Price Monitoring Extn
28th Aug 202011:00 amRNSPrice Monitoring Extension
28th Aug 20208:31 amRNSBeximco and SII to cooperate on a COVID-19 vaccine
30th Jul 20207:00 amRNSBoard Change
23rd Jun 20207:00 amRNSQ3 Financial Results and Business Update
21st May 20207:00 amRNSWorld’s first generic remdesivir for COVID-19
4th May 20207:00 amRNSCOVID-19 Update
30th Mar 20207:00 amRNSBeximco donates PPE to healthcare professionals
24th Feb 20207:00 amRNSBeximco announces Commercial Agreement with Mylan
29th Jan 20207:00 amRNSHalf Year Results 2019-20
20th Jan 202011:06 amRNSPayment of Cash Dividend
23rd Dec 201910:46 amRNSAGM Statement
19th Nov 20198:57 amRNSAGM Notification
14th Nov 20197:00 amRNSResults for First Quarter Ended 30 September 2019
11th Nov 20197:00 amRNSResults for the 12 month period ended 30 June 2019
29th Oct 20197:00 amRNSNotification of Preliminary Results and AGM
8th Aug 20199:18 amRNSUpdate on Dividend and Tax legislation changes
30th Jul 20197:00 amRNSBeximco launches fifth product in the US market
18th Jul 20194:01 pmRNSDividend and Tax changes for Bangladesh companies
29th Apr 20197:00 amRNS3rd Quarter Results
24th Apr 20197:00 amRNSBeximco receives FDA approval for Cyproheptadine
20th Feb 20197:00 amRNSBeximco Pharma to Acquire Eight ANDAs from Sandoz
4th Feb 201911:32 amRNSAppointment of Broker
31st Jan 20197:00 amRNSHalf Year Results 2018-19
22nd Jan 20197:00 amRNSPayment of Cash Dividend
27th Dec 20187:00 amRNSAGM Statement
27th Dec 20187:00 amRNSEGM Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.